{
	"GNOM_news": [
		{
			"stock": "GILD",
			"news_titles": [
				"With 86% institutional ownership, Gilead Sciences, Inc. (NASDAQ:GILD) is a favorite amongst the big guns",
				"Gilead to Present Latest Innovative Virology Data on Current and Potentially Transformative Therapies Across HIV and COVID-19 at IDWeek 2023",
				"Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know",
				"Gilead Board Director Kevin E. Lofton Named to List of Influential Leaders",
				"3 Magnificent Dividend Stocks to Buy in October",
				"20 Countries with Lowest Teenage Pregnancy Rates in the World",
				"Here's Why We Think Gilead Sciences (NASDAQ:GILD) Might Deserve Your Attention Today",
				"Gilead Sciences (GILD) Gains As Market Dips: What You Should Know"
			]
		},
		{
			"stock": "E",
			"news_titles": [
				"Eni (E) Makes a Significant Gas Discovery in Indonesia",
				"AppLovin and Gildan Activewear have been highlighted as Zacks Bull and Bear of the Day",
				"3 Oil Companies Leading in Renewable Energy Investment",
				"Shell (SHEL) Looks to Sell a Stake in Sprng Energy Assets",
				"Eni's (E) Plenitude Initiates Solar Power Project in Kazakhstan",
				"Eni (E) Secures 2 Out of 4 Blocks in Egypt's Oil & Gas Auction",
				"Eni SpA (E): A Deep Dive into its Dividend Performance and Sustainability",
				"Eni's (E) Hewett Project in U.K. Secures CO2 Storage License"
			]
		},
		{
			"stock": "MRNA",
			"news_titles": [
				"These 2 Top Stocks Are Screaming Buys Right Now",
				"This Could be Novavax's Big Opportunity",
				"Goldman Sachs Says These 2 Stocks Could Double Your Money — Here’s Why They Could Jump",
				"Did Moderna Just Jump Ahead of Rivals in a Potential Billion-Dollar Market?",
				"The Zacks Analyst Blog Highlights Novavax, ALX Oncology, Regeneron Pharmaceuticals, Intellia and Moderna",
				"Pfizer resolves Promosome patent lawsuit over COVID-19 vaccine",
				"Biotech Stock Roundup: NVAX Up on Updates, ALXO Gains on Study Data & More",
				"Moderna (MRNA) to Advance COVID/Flu Combo Jab to Late-Stage Study"
			]
		},
		{
			"stock": "A",
			"news_titles": [
				"Is It Too Late to Buy Apple Stock?",
				"5 Top Buffett Stocks to Buy and Hold for the Long Haul",
				"Smartphones Are Stuck in a Rut. AI Could Be the Cure.",
				"10 Best Rugged Smartphones in 2023",
				"Apple reportedly seeking Formula 1 streaming rights",
				"3 Top Gaming Stocks to Buy in October",
				"12 Best Artificial Intelligence (AI) Stocks To Buy According to Hedge Funds",
				"Google, Apple face fines in South Korea for breaching in-app billing rules"
			]
		},
		{
			"stock": "NVTA",
			"news_titles": [
				"Invitae's Common Hereditary Cancers Panel Receives FDA Market Authorization",
				"Why Invitae Stock Popped Today",
				"Invitae Announces Appointment of Finance Veteran Ana Schrank as CFO",
				"Invitae Receives Notice of Non-Compliance with NYSE Minimum Share Price Continued Listing Standard",
				"Invitae aims to regain NYSE compliance after average share price falls below $1",
				"Invitae Stock Analysis: Buy, Sell, or Hold?",
				"Novavax and Invitae implement cost-cutting measures amid financial challenges",
				"Cathie Wood Is Betting on This Struggling Stock. Should You?"
			]
		}
	]
}